Dexamethasone Treatment of Congenital Adrenal Hyperplasia
Adrenal HyperplasiaCongenitalThe purpose of this study is to determine if dexamethasone given at night is a more effective treatment for congenital adrenal hyperplasia in young children than standard three times per day hydrocortisone. Our hypothesis is that nocturnal dexamethasone will lead to more efficient suppression of the hypothalamic-pituitary-adrenal axis. We performed a cross-over trial comparing hormonal control during two 24-hour hospitalizations, one on hydrocortisone and one on nocturnal dexamethasone.
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract...
Prostatic HyperplasiaProstateStudy to look at safety and effectiveness of different doses of tadalafil on prostate related genital/urinary tract problems.
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary...
Benign Prostatic HyperplasiaPrimary: Evaluate the safety and onset of symptom relief using an acute I-PSS form (7 day form). Determine onset of urinary peak flow improvement after 7 days Secondary: Determine improvement in Bother Score after 7 & 28 days; improvement in sexual function after 28 days; assess one-month efficacy and safety
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
Prostatic HyperplasiaDutasteride and tamsulosin are to treat benign prostatic hyperplasia. Studies show that when given together, there is more improvement in symptoms than either drug alone. In this study, we are looking to see if 2 different formulations of tamsulosin in our combination capsules are the same after 7 days of dosing as the US commercial tamsulosin and dutasteride.
Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to...
Benign Prostatic HyperplasiaLower Urinary Tract SymptomsThis is a phase 1 study to evaluate the safety and effectiveness of using the Litx™ BPH System in patients with LUTS due to benign prostatic hyperplasia (BPH).
Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign...
Benign Prostatic HyperplasiaThe primary objective is to assess the dose-response relationship of SL77.0499 10 (alfuzosin hydrochloride) 5 mg, 10 mg, 15 mg, and placebo once daily during a 12-week oral administration period for the efficacy in patients with lower urinary tract symptoms (LUTS) related to BPH. Secondary objectives are to assess the efficacy of each dose of alfuzosin as compared with placebo and to assess the safety of each dose of alfuzosin.
Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women
Atypical Endometrial PolypsAtypical Endometrial HyperplasiaThe study aims to evaluate the long-term efficacy and prognosis of hysteroscopic resection and coagulation of the base of endometrial polyps with focal atypia in fertile women.
A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia
Vulvar DysplasiaVaginal DysplasiaTo compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias To compare healing related complications, post-operative pain, and scarring between the two procedures.
Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic...
Benign Prostatic HyperplasiaThis study is a randomized, double-blind, placebo and tamsulosin-controlled, parallel design, multinational study to evaluate the efficacy and safety of Tadalafil once-a-day dosing for 12 weeks in Asian men with signs and symptoms of benign prostatic hyperplasia (BPH).
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption...
Lower Urinary Tract SymptomsBenign Prostatic HyperplasiaClinical study to examine the safety, tolerability and efficacy of long-term combination therapy of tamsulosin and solifenacin in the treatment of males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) with a substantial storage component.